Natural products: evidence for neuroprotection to be exploited in glaucoma

A Adornetto, L Rombolà, LA Morrone, C Nucci… - Nutrients, 2020 - mdpi.com
Glaucoma, a leading cause of irreversible blindness worldwide, is an optic neuropathy
characterized by the progressive death of retinal ganglion cells (RGCs). Elevated intraocular …

Influence of circadian rhythm in the eye: significance of melatonin in glaucoma

A Martínez-Águila, A Martín-Gil, C Carpena-Torres… - Biomolecules, 2021 - mdpi.com
Circadian rhythm and the molecules involved in it, such as melanopsin and melatonin, play
an important role in the eye to regulate the homeostasis and even to treat some ocular …

Is there sufficient evidence that the melatonin binding site MT3 is quinone reductase 2?

JA Boutin, G Ferry - Journal of Pharmacology and Experimental …, 2019 - ASPET
In the 1980s, researchers used binding studies to show that there is a melatonin binding site
in addition to the receptors described previously. It was first termed ML2 and then, in 1999 …

The role and therapeutic potential of melatonin in age‐related ocular diseases

A Crooke, F Huete‐Toral, B Colligris… - Journal of pineal …, 2017 - Wiley Online Library
The eye is continuously exposed to solar UV radiation and pollutants, making it prone to
oxidative attacks. In fact, oxidative damage is a major cause of age‐related ocular diseases …

Melatonin and the control of intraocular pressure

HA Alkozi, G Navarro, R Franco, J Pintor - Progress in retinal and eye …, 2020 - Elsevier
Melatonin is not only synthesized by the pineal gland but by several ocular structures. This
natural indoleamine is of great importance for regulating several eye processes, among …

Novel therapies for glaucoma: a patent review (2013-2019)

P Guglielmi, S Carradori, C Campestre… - Expert Opinion on …, 2019 - Taylor & Francis
Introduction: Glaucoma is one of the main leading causes of irreversible blindness in the
world. The treatment of this disease relies on the use of drugs able to reduce/control the …

Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients

N Pescosolido, V Gatto, A Stefanucci… - Ophthalmic and …, 2015 - Wiley Online Library
Purpose Agomelatine is an agonist of melatonin that is used in the treatment of major
depressive disorders. It has also shown an ability to decrease IOP in experiment animals …

Secondary glaucoma: Toward interventions based on molecular underpinnings

A Mueller, I Lam, K Kishor, RK Lee… - WIREs Mechanisms …, 2024 - Wiley Online Library
Glaucoma is a heterogeneous group of progressive diseases that leads to irreversible
blindness. Secondary glaucoma refers to glaucoma caused by a known underlying …

Effect of melatonin and 5-methoxycarbonylamino-N-acetyltryptamine on the intraocular pressure of normal and glaucomatous mice

A Martínez-Águila, B Fonseca, MJP de Lara… - Journal of pharmacology …, 2016 - ASPET
Melatonin is a neurohormone that is produced not only by the pineal gland but also by
several ocular structures. One of the main physiologic roles of melatonin is the reduction of …

A topical formulation of melatoninergic compounds exerts strong hypotensive and neuroprotective effects in a rat model of hypertensive glaucoma

M Dal Monte, M Cammalleri, R Amato… - International Journal of …, 2020 - mdpi.com
Melatonin is of great importance for regulating several eye processes, including pressure
homeostasis. Melatonin in combination with agomelatine has been recently reported to …